Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Chinese astronauts’ return to Earth delayed over fears spaceship damaged by debris05.11.2025 - 2Vote in favor of Your #1 4K television: Lucidity and Drenching Matter05.06.2024
- 3Addressing sleep apnea early might decrease chances of developing Parkinson's disease25.11.2025
- 4The most effective method to Consummate the Specialty of Handshaking in Business and Group environments19.10.2023
- 5Nigeria police charge Joshua driver with dangerous driving over fatal crash02.01.2026
- Poll: Only 25% of Americans think Trump has 'followed through' on his promise to release the Epstein files
- UAE recalls some Nestle infant formula products, Qatar warns consumers
- The Golden Globes gift bag has nearly $1 million worth of swag for some winners and presenters. What's in it?
- Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed
- 10 Setting up camp Shelters That Offer Both Excellence and Isolation
- Why home maintenance deserves a spot in the annual health and budget plans
- The Leonid meteor shower is peaking early this week. Here’s what to know
- More parents refusing this shot that prevents serious bleeding at birth
- Burger King launches 'SpongeBob' menu ahead of film's release. A look at the Bikini Bottom-inspired meal, plus what taste testers are saying.
